Treatment shows promise as adjunctive calciphylaxis therapy

02/14/2013 | Healio

Thrombolytic tissue plasminogen activator was associated with a 30% increase in the survival rate for patients with calciphylaxis, according to a study in the journal JAMA Dermatology. Complications included major and minor bleeding, and six out of 15 patients had blood transfusions.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA